mRNA vaccine provides enhanced protection against mpox
The mRNA vaccine candidate more effectively limited symptoms and disease duration in non-human primates.
List view / Grid view
The mRNA vaccine candidate more effectively limited symptoms and disease duration in non-human primates.
Canadian researchers underwent a modelling study to explore optimal allocation of vaccines against monkeypox virus (MPXV), that prioritises vaccines to larger networks with more initial infections and greater potential for spread is best.
Researchers show how monkeypox mutations cause virus to replicate, spread faster.
The World Health Organization has declared monkeypox a Public Health Emergency of International Concern, the highest level of alert.
Governments outside of Africa have launched limited vaccinations to fight against the rising number of monkeypox cases.
Researchers report that removing the vSLFN gene from the ectromelia virus (ECTV) caused a potent immune response which protected animal models.
To spread throughout the body, the vaccinia virus mimics the infected cells' own proteins enabling the cell to move around and spread...